RecruitingPhase 2NCT06485778
A Study of Radiation Therapy After Surgery in People With Oral Tongue Squamous Cell Carcinoma
Studying Squamous cell carcinoma of the oral tongue
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Principal Investigator
- Sean McBride, MD, PhDMemorial Sloan Kettering Cancer Center
- Intervention
- Photon intensity modulated radiation therapy (IMRT)(radiation)
- Enrollment
- 24 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2024 – 2026
Study locations (7)
- Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States
- Memorial Sloan Kettering Suffolk - Commack, Commack, New York, United States
- Memorial Sloan Kettering Westchester, Harrison, New York, United States
- Memorial Sloan Kettering Cancer Center, New York, New York, United States
- Memorial Sloan Kettering Nassau, Uniondale, New York, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06485778 on ClinicalTrials.govOther trials for Squamous cell carcinoma of the oral tongue
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07402525Postoperative Radiotherapy for Early-stage Oral Tongue Squamous Cell Carcinoma Patients With Risk Factors: a Prospective, Multicenter, Randomized Controlled, Open-labelled TrialSecond Affiliated Hospital, School of Medicine, Zhejiang University
- RECRUITINGNCT07343271Dual-energy CT vs. MRI in the Evaluation of Squamous Cell Carcinomas of the Oral Cavity and OropharynxUniversity Hospital, Strasbourg, France
- RECRUITINGNCT06055868People Living With HIV, Oral and Oropharyngeal Cancer, and Health EquityUniversity of California, San Francisco
- RECRUITINGPHASE2, PHASE3NCT05893888Safety and Efficacy Study of PRV111 and PRV211 in Subjects With Oral Squamous Cell CarcinomaPrivo Technologies
- RECRUITINGNCT06321003SYsteMatical Trained learnIng aLgorithms for Oral carcInogenesiS Interpretation by Optical Coherence TomographyUniversity of Palermo
- RECRUITINGPHASE3NCT05798793Neoadjuvant Anti-PD-1 Immunotherapy With Chemotherapy in Resectable Locally Advanced Oral Squamous Cell CarcinomaHospital of Stomatology, Wuhan University
- ACTIVE NOT RECRUITINGPHASE2NCT06009861Neoadjuvant Tislelizumab Plus Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer (NeoSPOT)Peking University Hospital of Stomatology
- RECRUITINGPHASE2NCT05862168Neoadjuvant Treatment of Tislelizumab Combined Chemotherapy for Locally Advanced Oral Squamous Cell Carcinoma ：A Single-arm, Prospective, Phase II TrialWeijia Fang, MD
See all trials for Squamous cell carcinoma of the oral tongue →